Muniru Sewanyina
ID: UNCST-2021-R013988
|
CORPORATE GOVERNANCE PRACTICES AND NON-PERFORMING LOANS OF COMMERCIAL BANKS IN GREATER BUSHENYI DISTRICTS; WESTERN UGANDA
REFNo: SS3114ES
To ascertain the moderating influence of interest rates on non-performing loans of commercial banks in Greater Bushenyi Districts, western Uganda, To examine the extent to which board compensation influences non-performing loans of commercial banks in Greater Bushenyi Districts western Uganda ,To determine the extent to which relationship between shareholders\' rights and non-performing loans of commercial banks in Greater Bushenyi Districts, western Uganda,To examine the extent to which financial transparency influences non-performing loans of commercial banks in Greater Bushenyi Districts, western Uganda ,To assess the extent to which board accountability influences non-performing loans of commercial banks in Greater Bushenyi Districts, western Uganda, The purpose of this study will be to assess the effect of corporate governance practices on non-performing loans of commercial banks in Greater Bushenyi Districts; Western Uganda,
|
Uganda |
2024-09-23 12:16:25 |
2027-09-23 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Helen Byakwaga
ID: UNCST-2019-R001168
|
CD4 Cell Count at Antiretroviral Therapy Initiation or Re-initiation (CAIR)
REFNo: HS4944ES
To assess advanced HIV disease among people living with HIV initiating or re-initiating ART
1) Assess the proportion of participants presenting with advanced HIV disease prior to ART initiation/re-initiation among those enrolling in HIV care via CD4 cell count testing and WHO staging.
2) Description of participants re-entering care based on viral suppression and/or self-report of HIV care.
3) Assess barriers to HIV care including barriers associated with mental health and alcohol use.
4) Pilot test data variables to capture re-entry into care and re-initiation of ART and barriers to
HIV care and ART
|
Uganda |
2024-09-23 12:08:10 |
2027-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
MUGABE AMOS
ID: UNCST-2023-R007328
|
OCCURRENCE, ANTIMICROBIAL AND HEAT RESISTANCE PROFILES OF SALMONELLA SPECIES IN THE INFORMAL DAIRY VALUE CHAIN OF UGANDA
REFNo: A514ES
5. Evaluate the heat resistance profiles of Salmonella in the dairy value chain.,4. Evaluate the antibiotic resistance profiles of Salmonella in the dairy value chain.,3. Determine the serotypes of Salmonella in the dairy value chain. ,2. Estimate the prevalence of Salmonella in the dairy value chain.,1. Determine the extent to which milk producers and handlers in the dairy value chain are aware of milk quality and best dairy practices. ,To assess the serotypes, antibiotic resistance and heat resistance profiles of Salmonella in the dairy chain.,
|
Uganda |
2024-09-23 12:05:28 |
2027-09-23 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Emmanuel Mande
ID: UNCST-2023-R007045
|
Artemisinin Resistance Surveillance Network in Sub-Saharan Africa (ARSUNA)
REFNo: HS4644ES
To evaluate socio-demographic, clinical and malaria-history factors on treatment outcome and on the carriage of resistant malaria parasites.,To evaluate day 3 parasitemia among 200 patients with P. falciparum malaria treated with an ACT.,To assess the relatedness and origin of P. falciparum isolates with an artemisinin resistant geno- and phenotype by molecular analysis. ,To evaluate the in vitro susceptibility to (dihydro) artemisinin and ACT partner drugs (e.g. lumefantrine) among selected/suspicious P. falciparum isolates.,To assess the molecular characteristics of P. falciparum isolates from 200 patients with malaria, with a special focus on, but not limited to, molecular markers of artemisinin resistance, e.g., K13, and Pfmdr1.,
|
Uganda |
2024-09-23 11:59:33 |
2027-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
BOSCO AGABA BEKIITA
ID: UNCST-2019-R000549
|
Uganda Malaria Indicator Survey 2024
REFNo: HS4950ES
To determine risk factors for malaria parasitemia in Uganda,To measure indicators of knowledge, attitudes, and behaviour related to malaria control in Uganda (Community prevention and control efforts, Malaria vaccine knowledge and acceptance),To estimate core malaria programme coverage indicators in Uganda (Measure the extent of ownership, use and disposal of mosquito bed nets ● Assess coverage of the IPTp programme for pregnant women ● Coverage and uptake of IRS ● Identify practices used to treat malaria among children under age 5 and the use of specific antimalarial medications ● Assess percent of children under five with suspected or confirmed malaria who received treatment with ACTs within 24 hours of onset of fever. ● Access to malaria testing/ diagnosis ● Coverage, attitudes, and perceptions about SMC ● Determine the species of plasmodium parasite most prevalent in Uganda ),To obtain estimates of the magnitude and distribution of malaria parasitemia among children aged 6-59 months in Uganda,The main objective of the UMIS is to obtain population-based estimates of malaria indicators including the prevalence of malaria, to inform strategic planning and programme evaluation,
|
Uganda |
2024-09-23 11:57:13 |
2027-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|